Microba Merger with GSS Not Proceeding
Key points
- Merger with Genetic Signatures Limited (GSS) not proceeding
- Microba lacks financial capacity to complete merger
- Microba exploring alternative funding options
Full summary
Microba Life Sciences Ltd (ASX: MAP) has announced that the proposed merger with Genetic Signatures Limited (ASX: GSS) will not proceed. This decision follows Microba's inability to secure additional capital required to complete the merger. The merger was initially proposed and discussed for several months, but revisions to the terms made it impossible for Microba to meet the conditions of its institutional placement announced on 20 October 2026. Microba is now exploring alternative funding options while remaining in voluntary suspension.
Summary generated by a large language model. Please interpret with care.